CellforCure is a France-based contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products (ATMPs), with core expertise in cell and gene therapies such as CAR‑T and other immune cell therapies. The company supports biotechnology and pharmaceutical developers with compliant, scalable production for clinical and commercial supply.
Its services span process and analytical development, technology transfer, GMP manufacturing, in‑house quality control, and batch release under European regulatory frameworks, with capabilities to support multinational studies and market supply. CellforCure’s operations emphasize end‑to‑end integration, from starting material handling through final drug product, serving both autologous and allogeneic therapy programs.
